{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-078902","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2022-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.831162+00:00","generated_at":"2026-06-21T05:58:10.272649+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Oramed posts investor presentation; no new material financial or operational data disclosed","bullets":["Filed an investor presentation dated December 12, 2022 on its website.","Presentation titled 'Addressing the Multibillion-Dollar Injectable Drug Markets with Oral Formulations' provides a general overview.","No specific financial updates, guidance changes, or pipeline milestones were included in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-078902","json":"https://secwatch.observer/filing/0001213900-22-078902.json","markdown":"https://secwatch.observer/filing/0001213900-22-078902.md","text":"https://secwatch.observer/filing/0001213900-22-078902.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022078902/0001213900-22-078902-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022078902/ea169983-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T05:58:10.272649+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}